Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS??? EQUITY, PARTNERS??? CAPITAL AND REDEEMABLE NONCONTROLLING INTEREST

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY, PARTNERS’ CAPITAL AND REDEEMABLE NONCONTROLLING INTEREST - USD ($)
$ in Thousands
Total
IPO
Culture Kings
Common Stock
Common Stock
IPO
Common Stock
Culture Kings
Partnership Units
Additional Paid-In Capital
Additional Paid-In Capital
IPO
Additional Paid-In Capital
Culture Kings
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2020       0                  
Beginning balance at Dec. 31, 2020       $ 0                  
Total Stockholders’ Equity                          
Equity-based compensation $ 523             $ 523          
Net loss 1,790                     $ 1,472 $ 318
Ending balance (in shares) at Mar. 31, 2021       0                  
Ending balance at Mar. 31, 2021       $ 0                  
Beginning balance (in shares) at Dec. 31, 2020       0                  
Beginning balance at Dec. 31, 2020       $ 0                  
Beginning balance (in shares) at Dec. 31, 2020 [1]             114,167,842            
Beginning balance at Dec. 31, 2020 138,884           $ 108,197 [1] 727     $ 5,839 14,138 9,983
Partnership Equity                          
Issuance of units (in shares) [1]             25,746,282            
Issuance of units 82,669           $ 82,669 [1]            
Equity-based compensation 523             523          
Cumulative translation adjustment (3,842)                   (3,444)   (398)
Net income 1,790                     1,472 318
Ending balance (in shares) at Mar. 31, 2021 [1]             139,914,124            
Ending balance at Mar. 31, 2021 220,024           $ 190,866 [1] 1,250     2,395 15,610 9,903
Ending balance (in shares) at Mar. 31, 2021       0                  
Ending balance at Mar. 31, 2021       $ 0                  
Beginning balance at Dec. 31, 2020 0                        
Redeemable Noncontrolling Interest                          
Noncontrolling interest from purchase of Culture Kings 142,717                        
Cumulative translation adjustment (1,575)                        
Ending balance at Mar. 31, 2021 141,142                        
Beginning balance (in shares) at Dec. 31, 2020       0                  
Beginning balance at Dec. 31, 2020       $ 0                  
Total Stockholders’ Equity                          
Cumulative translation adjustment (31,245)                        
Net loss (6,114)                        
Ending balance (in shares) at Sep. 30, 2021       126,590,142                  
Ending balance at Sep. 30, 2021       $ 127                  
Beginning balance (in shares) at Dec. 31, 2020       0                  
Beginning balance at Dec. 31, 2020       $ 0                  
Beginning balance (in shares) at Dec. 31, 2020 [1]             114,167,842            
Beginning balance at Dec. 31, 2020 138,884           $ 108,197 [1] 727     5,839 14,138 9,983
Partnership Equity                          
Net income (6,114)                        
Ending balance (in shares) at Sep. 30, 2021             0            
Ending balance at Sep. 30, 2021 408,909           $ 0 415,341     (14,706) 8,147 0
Ending balance (in shares) at Sep. 30, 2021       126,590,142                  
Ending balance at Sep. 30, 2021       $ 127                  
Beginning balance at Dec. 31, 2020 0                        
Ending balance at Sep. 30, 2021 0                        
Beginning balance (in shares) at Mar. 31, 2021       0                  
Beginning balance at Mar. 31, 2021       $ 0                  
Total Stockholders’ Equity                          
Equity-based compensation 609             609          
Ending balance (in shares) at Jun. 30, 2021       0                  
Ending balance at Jun. 30, 2021       $ 0                  
Beginning balance (in shares) at Mar. 31, 2021       0                  
Beginning balance at Mar. 31, 2021       $ 0                  
Beginning balance (in shares) at Mar. 31, 2021 [1]             139,914,124            
Beginning balance at Mar. 31, 2021 220,024           $ 190,866 [1] 1,250     2,395 15,610 9,903
Partnership Equity                          
Equity-based compensation 609             609          
Cumulative translation adjustment (3,846)                   (3,709)   (137)
Net loss 2,684                     2,431 253
Ending balance (in shares) at Jun. 30, 2021 [1]             139,914,124            
Ending balance at Jun. 30, 2021 219,471           $ 190,866 [1] 1,859     (1,314) 18,041 10,019
Ending balance (in shares) at Jun. 30, 2021       0                  
Ending balance at Jun. 30, 2021       $ 0                  
Beginning balance at Mar. 31, 2021 141,142                        
Redeemable Noncontrolling Interest                          
Cumulative translation adjustment (1,835)                        
Net loss (495)                        
Ending balance at Jun. 30, 2021 138,812                        
Total Stockholders’ Equity                          
Equity-based compensation 5,582             5,582          
Cumulative translation adjustment (20,146)                        
Net loss (10,093)                        
Ending balance (in shares) at Sep. 30, 2021       126,590,142                  
Ending balance at Sep. 30, 2021       $ 127                  
Beginning balance (in shares) at Jun. 30, 2021       0                  
Beginning balance at Jun. 30, 2021       $ 0                  
Partnership Equity                          
Purchase of Petal & Pup noncontrolling interest (20,198)             (10,599)         (9,599)
Purchase of Culture Kings noncontrolling interest (in shares)           21,809,804              
Purchase of Culture Kings noncontrolling interest     $ 132,278     $ 22       $ 132,256      
Reorganization transactions (in shares)       94,780,338     (139,914,124)            
Reorganization transactions 0     $ 95     $ (190,866) 190,771          
Issuance of common stock upon initial public offering, net of issuance costs (in shares)         10,000,000                
Issuance of common stock upon initial public offering, net of issuance costs   $ 95,482     $ 10       $ 95,472        
Equity-based compensation 5,582             5,582          
Cumulative translation adjustment (13,863)                   (13,392)   (471)
Net income (10,093)                        
Net loss (9,843)                     (9,894) 51
Ending balance (in shares) at Sep. 30, 2021             0            
Ending balance at Sep. 30, 2021 408,909           $ 0 415,341     (14,706) 8,147 $ 0
Ending balance (in shares) at Sep. 30, 2021       126,590,142                  
Ending balance at Sep. 30, 2021       $ 127                  
Redeemable Noncontrolling Interest                          
Purchase of Culture Kings noncontrolling interest (132,278)                        
Cumulative translation adjustment (6,283)                        
Net loss (251)                        
Ending balance at Sep. 30, 2021 $ 0                        
Beginning balance (in shares) at Dec. 31, 2021 128,647,836     128,647,836                  
Beginning balance at Dec. 31, 2021 $ 451,026     $ 129       453,807     (11,080) 8,170  
Total Stockholders’ Equity                          
Equity-based compensation 1,368             1,368          
Cumulative translation adjustment 14,405                   14,405    
Net loss 1,525                     1,525  
Ending balance (in shares) at Mar. 31, 2022       128,647,836                  
Ending balance at Mar. 31, 2022 $ 468,324     $ 129       455,175     3,325 9,695  
Beginning balance (in shares) at Dec. 31, 2021 128,647,836     128,647,836                  
Beginning balance at Dec. 31, 2021 $ 451,026     $ 129       453,807     (11,080) 8,170  
Partnership Equity                          
Equity-based compensation 1,368             1,368          
Net income 1,525                     1,525  
Ending balance (in shares) at Mar. 31, 2022       128,647,836                  
Ending balance at Mar. 31, 2022 $ 468,324     $ 129       455,175     3,325 9,695  
Beginning balance (in shares) at Dec. 31, 2021 128,647,836     128,647,836                  
Beginning balance at Dec. 31, 2021 $ 451,026     $ 129       453,807     (11,080) 8,170  
Total Stockholders’ Equity                          
Cumulative translation adjustment (52,889)                        
Net loss $ (2,801)                        
Ending balance (in shares) at Sep. 30, 2022 128,814,790     128,814,790                  
Ending balance at Sep. 30, 2022 $ 399,699     $ 129       458,170     (63,969) 5,369  
Beginning balance (in shares) at Dec. 31, 2021 128,647,836     128,647,836                  
Beginning balance at Dec. 31, 2021 $ 451,026     $ 129       453,807     (11,080) 8,170  
Partnership Equity                          
Net income $ (2,801)                        
Ending balance (in shares) at Sep. 30, 2022 128,814,790     128,814,790                  
Ending balance at Sep. 30, 2022 $ 399,699     $ 129       458,170     (63,969) 5,369  
Beginning balance (in shares) at Mar. 31, 2022       128,647,836                  
Beginning balance at Mar. 31, 2022 468,324     $ 129       455,175     3,325 9,695  
Total Stockholders’ Equity                          
Equity-based compensation 1,494             1,494          
Issuance of common stock upon settlement of equity awards, net of shares withheld (in shares)       21,345                  
Issuance of common stock upon settlement of equity awards, net of shares withheld (32)             (32)          
Cumulative translation adjustment (39,031)                   (39,031)    
Net loss (4,212)                     (4,212)  
Ending balance (in shares) at Jun. 30, 2022       128,669,181                  
Ending balance at Jun. 30, 2022 426,543     $ 129       456,637     (35,706) 5,483  
Beginning balance (in shares) at Mar. 31, 2022       128,647,836                  
Beginning balance at Mar. 31, 2022 468,324     $ 129       455,175     3,325 9,695  
Partnership Equity                          
Equity-based compensation 1,494             1,494          
Net income (4,212)                     (4,212)  
Ending balance (in shares) at Jun. 30, 2022       128,669,181                  
Ending balance at Jun. 30, 2022 426,543     $ 129       456,637     (35,706) 5,483  
Total Stockholders’ Equity                          
Equity-based compensation 1,586             1,586          
Issuance of common stock upon settlement of equity awards, net of shares withheld (in shares)       145,609                  
Issuance of common stock upon settlement of equity awards, net of shares withheld (53)             (53)          
Cumulative translation adjustment (28,263)                   (28,263)    
Net loss $ (114)                     (114)  
Ending balance (in shares) at Sep. 30, 2022 128,814,790     128,814,790                  
Ending balance at Sep. 30, 2022 $ 399,699     $ 129       458,170     (63,969) 5,369  
Beginning balance (in shares) at Jun. 30, 2022       128,669,181                  
Beginning balance at Jun. 30, 2022 426,543     $ 129       456,637     (35,706) 5,483  
Partnership Equity                          
Equity-based compensation 1,586             1,586          
Net income $ (114)                     (114)  
Ending balance (in shares) at Sep. 30, 2022 128,814,790     128,814,790                  
Ending balance at Sep. 30, 2022 $ 399,699     $ 129       $ 458,170     $ (63,969) $ 5,369  
[1] Excelerate, L.P. was the predecessor entity to a.k.a. Brands Holding Corp. Refer to Note 1 for additional information.